Meitav Dash Investments LTD Axogen, Inc. Transaction History

Meitav Dash Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $241,800 - $409,200	-20,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $1.36 Million - $1.88 Million	-73,644 Reduced 78.64%	20,000 $394,000
Q1 2019 May 13, 2019	BUY	$14.62 - $22.13 $126,375 - $191,291	8,644 Added 10.17%	93,644 $1.95 Million
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $905,770 - $2.03 Million	53,000 Added 165.63%	85,000 $1.64 Million
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $869,977 - $1.43 Million	25,550 Added 396.12%	32,000 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $233,167 - $338,625	6,450 New	6,450 $332,000

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.